Evidence map›Paper›PMID 28861476›Full record

ReviewCannabis and cannabinoid research2016

Allosteric Modulators of the CB

Paula Morales, Pilar Goya, Nadine Jagerovic, Laura Hernandez-Folgado

Open access · hybridAbstract readReview
In one paragraph

Review in Cannabis and cannabinoid research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
10.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Genetically Encoded CBInternational journal of molecular sciences · 2026
    Article
  7. Observational
  8. Article
  9. Review
  10. Research and Clinical Practice Involving the Use ofPharmaceuticals (Basel, Switzerland) · 2024
    Review
  11. Review
  12. Article
  13. Negative allosteric modulation of CBNeuropharmacology · 2024
    Article
  14. Potential of CBD Acting on Cannabinoid Receptors CBInternational journal of molecular sciences · 2024
    Review
  15. Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABInternational journal of molecular sciences · 2024
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Paula MoralesInstituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Pilar GoyaInstituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Nadine JagerovicInstituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Laura Hernandez-FolgadoInstituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Consejo Superior de Investigaciones Científicas · ESInstituto de Química Médica · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2005, the first evidence of an allosteric binding site at the CB

Indexed as

CB1Rsynthetic cannabinoids

Identifiers

PMID28861476
PMCPMC5576597
OpenAlexW2284281992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.